ORPHA:585942
B-lymphoblastic leukemia/lymphoma with hypodiploidy
Also known as: Hypodiploid ALL
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
301
79.5th percentile
Trials
0
Interventional, condition-specific
Researchers
1,304
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0035944
- UMLS:C2698312
- NCIT:C80338
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
301 matched papers (210 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
301
301 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
301 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
210 in the last 10 years · high confidence · 79.5th percentile (publications denominator)
Phrase hits: 301 · MeSH hits: 0
Who's working on it?
1,304
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Mullighan CG23 papers · 2024
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA. charles.mullighan@stjude.org
Papers in Europe PMC - 02Pui CH18 papers · 2024
Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Papers in Europe PMC - 03Hunger SP14 papers · 2024
Department of Preventative Medicine, University of Southern California, Los Angeles, CA, USA.
Papers in Europe PMC - 04Yang JJ12 papers · 2024
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN; and.
Papers in Europe PMC - 05Loh ML11 papers · 2024
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA; and.
Papers in Europe PMC - 06Devidas M8 papers · 2024
Children's Oncology Group Statistics and Data Center, Department of Biostatistics, The University of Florida, Gainesville, FL, USA.
Papers in Europe PMC - 07Carroll WL7 papers · 2024
Department of Pediatrics, NYU Medical Center, New York, NY, USA.
Papers in Europe PMC - 08Downing JR7 papers · 2021
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Papers in Europe PMC - 09Kantarjian H7 papers · 2025
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Papers in Europe PMC - 10Roberts KG7 papers · 2024
Department of Pathology, St. Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, Tennessee.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"B-lymphoblastic leukemia/lymphoma with hypodiploidy" OR "Hypodiploid ALL"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"B-lymphoblastic leukemia/lymphoma with hypodiploidy" OR "Hypodiploid ALL" OR "B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality" OR "precursor lymphoblastic lymphoma/leukemia"
Recall-expansion terms: B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality, precursor lymphoblastic lymphoma/leukemia
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T18:44:30.450Z